Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease and Controls

NCT03675282 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT03675282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03675282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease and Controls
Lead sponsor
Weill Medical College of Cornell University
Phase
Phase 1/2
Overall status
Completed
Start date
August 14, 2018
Completion date
April 23, 2024
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, parkinson disease, rem sleep behavior disorder